Top Markets
Coin of the day
Artemis Therapeutics Inc. Artemis Therapeutics Inc.

Artemis Therapeutics Inc.

ATMS
Rank in Stocks #24862
Artemis Therapeutics Inc. currently lacks substantial business operations.... Artemis Therapeutics Inc. currently lacks substantial business operations. Situated in New York, New York, this company previously concentrated on developing pharmaceutical agents to prevent and treat severe and life-threatening infectious diseases. It is a subsidiary of Tonak Ltd.
Share Price
$0.498
Last synced: 2023-05-25
Market Cap
$55.79M
Change (1 day)
-73.65%
Change (1 year)
0.00%
Country
US
Trade Artemis Therapeutics Inc. (ATMS)
P/E ratio for Artemis Therapeutics Inc. (ATMS)
P/E ratio as of 2026 TTM: 0
According to Artemis Therapeutics Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Artemis Therapeutics Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.